A Phase II Open Label Study of Xilonix in Subjects With Pyoderma Gangrenosum

计划入组 10 人 · 首次发布于 2013 年 10 月 18 日

A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer

计划入组 643 人 · 首次发布于 2013 年 1 月 14 日

Study of Gelonin Purging of Autologous Stem Cells for Transplantation

计划入组 3 人 · 首次发布于 2002 年 8 月 15 日

Staphylococcus aureus vaccine (Delonix Bioworks)

Pseudomonas aeruginosa vaccine (Delonix Bioworks)

Group B meningitis vaccine(Delonix Bioworks)

Ginkgo Bioworks

United States

Bugworks Research, Inc.

United States

Kelonia Therapeutics, Inc.

United States

Delonix Bioworks Receives Dual Regulatory Clearance for Novel MenB Vaccine DX-104 in China and Australia

Delonix Bioworks Doses First Participant in China Phase 1 Trial of Next-Generation MenB OMV Vaccine DX-104

Valion Bio's Velocity Bioworks Secures Exclusive License for Next-Generation NMR Diagnostic Platform